Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus

Lupus

Volumn 16, Issue 2, 2007, Pages 142-146

  Uziel, Yosef ^a,h   Gorodnitski, N ^a   Mukamel, M ^a   Padeh, S ^a   Brik, R ^b   Barash, J ^c   Mevorach, D ^c   Berkun, Y ^a   Tauber, T ^a   Press, J ^d   Harel, L ^a   Navon, P ^e   Rubenstein, M ^f   Naparstek, Y ^c   Hashkes, P J ^g  

^a TEL AVIV UNIVERSITY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e SHAARE ZEDEK MEDICAL CENTER   (Israel)

^f Cleveland Clinic Foundation ^*  (Israel)

^g LERNER RESEARCH INSTITUTE   (United States)

^h MEIR MEDICAL CENTER   (Israel)

Author keywords

Outcome; Pediatrics; SLEDAI; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DISEASE ACTIVITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; ISRAEL; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; REGISTRIES;

EID: 33847388384     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306075385     Document Type: Article

References (33)

1. Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin North Am 2005; 52: 443-467.
2. Fessel WJ. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 15-23.
3. Kaufman DB, Laxer RM, Silverman ED, Stein L. Systemic lupus erythematosus in childhood and adolescence - the problem, epidemiology, incidence, susceptibility, genetics, and prognosis. Curr Prob Pediatr 1986; 16: 555-624.
4. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology and outcome. Br J Rheumatol 1995; 34: 866-872.
5. Carreno L, Lopez-Longo FJ, Monteagudo I, Rodriguez-Mahou M, Bascones M, Gonzalez CM. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999; 8: 287-292.
6. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-459.
7. Costallat LTL, Coimbra AMV. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 1994; 12: 603-607.
8. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2002; 46: 436-444.
9. Font J, Cervera R, Ramos-Casals M et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 2004; 33: 217-230.
10. Rood MJ, ten Cate R, Van Suijlekom-Smit LWA, den Ouden EJ, Ouwerkerk FE, Breedveld FC. Childhood-onset systemic lupus erythematosus. Scand J Rheumatol 1999; 28: 222-226.
11. Ravelli A, Duarte-Salazar C, Buratti S et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49: 501-507.
12. Ruperto N, Ravelli A, Cuttica R et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 2854-2864.
13. Bader-Meunier B, Armengaud JB, Haddad E et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005; 146: 648-653.
14. Alsaeid K, Kamal H, Haider MZ, Al-Enezi HM, Malaviya AN. Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings. Lupus 2004; 13: 613-617.
15. Cassidy JT, Sullivan DB, Petty RE et al. Lupus nephritis and encephalopathy: prognosis in 58 children. Arthritis Rheum 1977; 20: 287-293.
16. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic and immunogenetic studies in childhood onset systemic lupus erythematosus. Arthritis Rheum 1993; 36: 348-354.
17. Lehman TJA, McCurdy D, Bernstein BH et al. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989; 83: 235-239.
18. King KK, Korenrich HK, Bernstein BH et al. The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 1977; 20: 287-294.
19. Brik R, Padeh S, Mukamel M et al. Systemic lupus erythematosus in children in Israel. Harefuah 1995; 129: 233-235.
20. Uziel Y, Hashkes PJ. The state of pediatric rheumatology in Israel. PROJ 2004; 2: 172-175 (electronic: http://www. pedrheumonlinejournal.org/).
21. Hashkes PJ, Uziel Y, Rubenstein M et al. The Israeli internet-based pediatric rheumatology registry: novel concept of multicenter data collection in pediatric rheumatology. PROJ 2004; 2: 37-50 (electronic: http://www.pedrheumonlinejournal.org/).
22. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. The committee on prognosis in SLE. Arthritis Rheum 1992; 35: 630-640.
24. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the systemic lupus erythematosus disease activity index, British, Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1354-1360.
25. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
26. Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: Result from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996; 23: 1981-1987.
27. Kaipiainen-Sappanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 1996; 14: 441-444.
28. Cameron JS. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 1994; 8: 230-249.
29. Parikh S, Swaiman KF, Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995; 13: 198-201.
30. Steinlin MI, Blaser SI, Gilday DL. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995; 13: 191-197.
31. Gedalia A, Molina JF, Garcia CO, Doggett S, Espinoza LR, Gharavi AE. Anticardiolipin antibodies in childhood rheumatic diseases. Lupus 1998; 7: 551-553.
32. Seaman DE, Londino AV Jr, Kwoh CK, Medsger TA Jr, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995; 96: 1040-1045.
33. Petri M. Epidemiology of the antiphospholipid antibody syndrome; J Autoimmun 2000; 15: 145-151.